Drug Profile
Daniplestim
Alternative Names: Interleukin-3 - Pharmacia; Interleukin-3 synthokine; SC 55494Latest Information Update: 12 Oct 2001
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Chemoprotectants
- Mechanism of Action Interleukin 3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stem cell mobilisation; Thrombocytopenia
Most Recent Events
- 12 Oct 2001 No-Development-Reported for Stem cell mobilisation in Spain (Unknown route)
- 12 Oct 2001 No-Development-Reported for Stem cell mobilisation in USA (Unknown route)
- 12 Oct 2001 No-Development-Reported for Thrombocytopenia in Japan (Unknown route)